ATE456302T1 - Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe - Google Patents

Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe

Info

Publication number
ATE456302T1
ATE456302T1 AT98946099T AT98946099T ATE456302T1 AT E456302 T1 ATE456302 T1 AT E456302T1 AT 98946099 T AT98946099 T AT 98946099T AT 98946099 T AT98946099 T AT 98946099T AT E456302 T1 ATE456302 T1 AT E456302T1
Authority
AT
Austria
Prior art keywords
arginine
administration
tissue
relief
warm cold
Prior art date
Application number
AT98946099T
Other languages
German (de)
English (en)
Inventor
Eric Fossel
Original Assignee
Strategic Science & Technologi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/936,189 external-priority patent/US6207713B1/en
Priority claimed from US08/932,227 external-priority patent/US7914814B2/en
Priority claimed from US08/936,188 external-priority patent/US5895658A/en
Priority claimed from US08/932,595 external-priority patent/US5922332A/en
Application filed by Strategic Science & Technologi filed Critical Strategic Science & Technologi
Application granted granted Critical
Publication of ATE456302T1 publication Critical patent/ATE456302T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
AT98946099T 1997-09-17 1998-09-17 Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe ATE456302T1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/936,189 US6207713B1 (en) 1997-09-17 1997-09-17 Topical and oral delivery of arginine to cause beneficial effects
US08/932,227 US7914814B2 (en) 1997-09-17 1997-09-17 Topical delivery of arginine of cause beneficial effects
US08/936,188 US5895658A (en) 1997-09-17 1997-09-17 Topical delivery of L-arginine to cause tissue warming
US08/932,595 US5922332A (en) 1997-09-17 1997-09-17 Topical delivery of arginine to overcome pain
PCT/US1998/019429 WO1999013717A1 (en) 1997-09-17 1998-09-17 A delivery of arginine to cause beneficial effects

Publications (1)

Publication Number Publication Date
ATE456302T1 true ATE456302T1 (de) 2010-02-15

Family

ID=27506014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946099T ATE456302T1 (de) 1997-09-17 1998-09-17 Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe

Country Status (8)

Country Link
EP (2) EP2158907B1 (enExample)
JP (3) JP4352114B2 (enExample)
AT (1) ATE456302T1 (enExample)
AU (1) AU737199B2 (enExample)
CA (1) CA2303394C (enExample)
DE (1) DE69841481D1 (enExample)
ES (2) ES2340450T3 (enExample)
WO (1) WO1999013717A1 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US6284797B1 (en) * 1999-04-12 2001-09-04 Donald A. Rhodes Topical treatment of pain and to promote healing
JP2000327560A (ja) * 1999-05-18 2000-11-28 Noevir Co Ltd 入浴剤組成物
FR2794974B1 (fr) * 1999-06-16 2001-08-17 Exsymol Sa Composition cosmetique pour l'amincissement a base de l-arginine, d'un analogue de l-arginine ou d'un de leurs derives, applicable par voie topique
US6322493B1 (en) * 1999-07-01 2001-11-27 40 J's Llc Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
DE10113446A1 (de) * 2001-03-19 2002-09-26 Schwarzkopf Gmbh Hans Haarbehandlungsmittel mit Betainen
JP4229842B2 (ja) * 2002-02-22 2009-02-25 ルバンス セラピュティックス インク． Ｌ−アルギニンオリゴマーを含む化粧品処方
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
AU2005216192B2 (en) * 2004-02-23 2010-11-04 Strategic Science & Technologies, Llc Topical delivery of a nitric oxide donor to improve body and skin appearance
JP2005281272A (ja) * 2004-03-31 2005-10-13 Suntory Ltd 末梢血流改善剤
JP4837896B2 (ja) * 2004-03-31 2011-12-14 焼津水産化学工業株式会社 精力増強剤
JP4836044B2 (ja) * 2004-04-02 2011-12-14 味の素株式会社 経口アミノ酸ニキビ治療剤
AU2005235308B2 (en) 2004-04-19 2011-12-01 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
AU2012201048B2 (en) * 2004-04-19 2013-06-06 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
EP2417978A1 (en) 2004-04-19 2012-02-15 Strategic Science & Technologies, LLC Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
JP2006169406A (ja) * 2004-12-16 2006-06-29 Fuji Latex Kk コンドーム用水性潤滑剤および当該潤滑剤を塗布したコンドーム
JP2008179540A (ja) * 2005-01-07 2008-08-07 Noevir Co Ltd 細胞分化、発生、増殖を制御する物質および該物質を含む細胞分化・発生・増殖調節剤
FR2883167B1 (fr) * 2005-03-18 2009-07-10 Oreal Composition de soin capillaire et/ou des cils contenant de l'aminexil en association avec un vasodilatateur, destinee a stimuler la croissance des cheveux et/ou des cils et/ou freiner leur chute, ses utilisations
WO2006097359A1 (en) * 2005-03-18 2006-09-21 L'oréal Hair and/or eyelash care composition containing aminexil in combination with an agent for promoting the no production and uses thereof
US8445536B2 (en) 2005-03-31 2013-05-21 Ajinomoto Co., Inc. Arginine-containing compositions and methods for increasing blood flow using same
JP5046174B2 (ja) * 2005-03-31 2012-10-10 味の素株式会社 アルギニン含有血流増加用組成物
JP5572318B2 (ja) 2005-12-30 2014-08-13 ルバンス セラピュティックス インク． 局所投与用アルギニンヘテロマー
WO2008089435A1 (en) * 2007-01-18 2008-07-24 Wyeth Methods of identifying pain modulators
WO2009036771A1 (es) * 2007-09-21 2009-03-26 Pharmabrand S.A. Composición de polisacáridos mucilaginosos, derivados de aloe barbadensis, en combinación con liposomas, procedimiento de obtención y uso de la misma como fotoprotectora, antiacné, regeneradora de la epidermis e hidratante
FR2929118B1 (fr) * 2008-03-28 2010-05-07 Oreal Utilisation de l'association de madecassoside et/ou de terminoloside et d'une arginine pour induire et/ou stimuler la croissance de ces fibres keratiniques humaines et/ou freiner leur chute
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2010151240A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
WO2010151241A1 (en) * 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
DK2658551T3 (da) 2010-12-29 2020-09-21 Strategic Science & Tech Llc Behandling af erektil dysfunktion og andre indikationer
CN105878172A (zh) 2010-12-29 2016-08-24 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
WO2014152280A1 (en) 2013-03-15 2014-09-25 Strategic Science & Technologies, Llc Transdermal formulations of fluticasone
EP2968130A1 (en) 2013-03-15 2016-01-20 Strategic Science & Technologies, LLC Transdermal delivery of sildenafil and other phosphodiesterase type 5 inhibitors
US10894024B2 (en) * 2014-12-08 2021-01-19 Synaptamine, Inc. Anti-RDS compounds and method of manufacture and administration thereof to induce dopamine homeostatis
WO2016112201A1 (en) 2015-01-07 2016-07-14 Strategic Science & Technologies, Llc Techniques and systems for transdermal delivery involving treatment of psoriasis, skin cancer, and other indications
MY176129A (en) * 2015-08-06 2020-07-24 Coats Agri Aloe Llc Compositions and methods to increase plant yield
GB201620701D0 (en) * 2016-12-06 2017-01-18 Glaxosmithkline Consumer Healthcare (Uk) Ip Ltd Novel composition
US10624907B2 (en) * 2017-04-12 2020-04-21 Performance Labs PTE. LTD. Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement
CN110870914A (zh) * 2018-08-31 2020-03-10 成都夸常奥普医疗科技有限公司 氨基酸类营养素的应用以及包含它的药物组合物
JP7642955B2 (ja) * 2021-02-04 2025-03-11 株式会社ファンケル 嗅覚受容体発現促進用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5940M (enExample) * 1966-10-18 1968-04-08
FR2602678B1 (fr) * 1986-08-13 1992-06-05 Drouault Guy Composition pharmaceutique aqueuse a base de sels de magnesium, sodium et potassium pour la regulation des circulations locales
DE69022678T2 (de) * 1989-10-17 1996-03-21 Merck & Co Inc S(+)-Ibuprofen-L-Aminosäure und S(+)-Ibuprofen-D-Aminosäure als Analgetika mit grösserem pharmakologischem Potential.
JPH045231A (ja) * 1990-04-20 1992-01-09 Morishita Pharmaceut Co Ltd 慢性痛用鎮痛剤
JPH0789862A (ja) * 1990-05-29 1995-04-04 Toyobo Co Ltd 抗炎症性、免疫抑制性および鎮痛性組成物、およびこれらの組成物を用いた自己免疫疾患の治療方法
DE4100975A1 (de) * 1991-01-15 1992-07-16 Weuffen Wolfgang Kosmetische oder pharmazeutische zubereitungen zur verbesserung der haarqualitaet und foerderung des haarwachstums
US5852058A (en) * 1993-06-11 1998-12-22 The Board Of Trustees Of The Leland Stanford Junior University Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury
DE4338793A1 (de) * 1993-11-12 1995-05-18 Froelich Juergen C L-Arginin und Analoge als Thrombozytenaggregationshemmer
DE4341000A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Verwendung von L-Arginin, L-Ornithin oder L-Citrullin und topischen Zubereitungen mit diesen Stoffen
US5594032A (en) * 1994-11-10 1997-01-14 Gonzalez-Cadavid; Nestor F. Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
US5734080A (en) * 1995-09-22 1998-03-31 Anihealth Corporation Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof

Also Published As

Publication number Publication date
AU9318698A (en) 1999-04-05
JP2015038119A (ja) 2015-02-26
EP1041880B1 (en) 2010-01-27
JP2002515401A (ja) 2002-05-28
EP1041880A4 (en) 2006-04-12
ES2340450T3 (es) 2010-06-02
JP2009143968A (ja) 2009-07-02
EP2158907A2 (en) 2010-03-03
EP2158907B1 (en) 2015-08-05
CA2303394A1 (en) 1999-03-25
CA2303394C (en) 2011-12-20
WO1999013717A1 (en) 1999-03-25
EP2158907A3 (en) 2010-05-26
WO1999013717B1 (en) 1999-04-22
AU737199B2 (en) 2001-08-09
EP1041880A1 (en) 2000-10-11
ES2549329T3 (es) 2015-10-27
DE69841481D1 (de) 2010-03-18
JP4352114B2 (ja) 2009-10-28

Similar Documents

Publication Publication Date Title
ATE456302T1 (de) Verabreichung von arginin zur erwärmung von kaltem/kühlem gewebe
US20010002405A1 (en) Topical and oral delivery of arginine to cause beneficial effects
ATE30209T1 (de) Verwendung von eukalyptol zur steigerung der resorption von bioaktiven substanzen durch die haut.
AU581121B2 (en) Skin treatment composition
NZ513154A (en) Therapeutic and/or cosmetic formulations comprising antisense polynucleotides to connexin proteins
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
ATE152356T1 (de) Topisches präparat zur besseren heilung von herpesverletzungen
GR3032224T3 (en) Therapeutic agent for threatened abortion.
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
PT1016414E (pt) Hormona de crescimento humano para estimular a hematopoiese e a reconstituicao imnologica apos transplante de celulas estaminais hematopoieticas em humanos
PT1140001E (pt) Composicao para tratamento de queimaduras
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
DE69825322D1 (de) Topische carbamazepin-formulierungen und deren verwendung
CA2115045A1 (en) Composition for Curing Proliferative Skin Diseases
EP1328273A4 (en) ADDITIVES AND METHODS FOR THE TRANSDERMAL APPLICATION OF FELODIPIN
CN1079667A (zh) 一种烫伤药
RU94032102A (ru) Способ лечения или облегчения боли, связанной со скелетно-мышечными, нервными или кожными заболеваниями, препараты на основе хлорида цезия, способ получения терапевтических препаратов, способ анестезирования
RU96100994A (ru) Лечебно-косметическое средство
UA29005A (uk) Спосіб лікування трофічних виразок нижніх кінцівок

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties